Trial Profile
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- Acronyms FIB-PPH
- 13 Jul 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 18 Aug 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2009-017736-41).
- 18 Jun 2012 Additional lead trial investigator (Edwards HM) added as reported by ClinicalTrials.gov.